Supplemental material
Leukemia & Lymphoma
Volume 60, 2019 - Issue 4
Original Article: Research
Characterization of two new high-grade B-cell lymphoma cell lines with MYC and BCL2 rearrangements that are suitable for in vitro drug sensitivity studies
, , , , , , 
, , & show all
Alessandra CamboniDepartment of Pathology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Tour Franklin, Brussels, Belgium; ;Department of Hematology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgiumhttp://orcid.org/0000-0001-5277-2668
http://orcid.org/0000-0001-5277-2668, , & Nicolas van BarenCellular Genetics Unit, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium; Correspondence[email protected]
http://orcid.org/0000-0003-4548-0266
http://orcid.org/0000-0003-4548-0266 show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
MYC-Positive Relapsed-Refractory DLBCL
Source:
Wiley
Current challenges and novel treatment strategies in double hit lymphomas
Source:
SAGE Publications
Diffuse Large B-Cell Lymphoma Lacking Surface B-Cell Receptor Expression Are Germinal Center B-Cell (GCB)-Type and Lack Evidence of Known Downstream Activating Mutations
Source:
American Society of Hematology
Correction: Refinement of 1p36 Alterations Not Involving PRDM16 in Myeloid and Lymphoid Malignancies
Source:
Public Library of Science (PLoS)
BCL6 role in GC B cells
Source:
Wiley
TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses
Source:
American Society of Hematology
An International System for Human Cytogenomic Nomenclature (2016)
Source:
S. Karger AG
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
Source:
American Society of Hematology
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Source:
Springer Science and Business Media LLC
Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas.
Source:
Oxford University Press (OUP)
TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations.
Source:
Informa UK Limited
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Source:
Springer Science and Business Media LLC
BCL2 mutations in diffuse large B-cell lymphoma
Source:
Springer Science and Business Media LLC
Epstein-Barr Virus Quantitation by Real-Time PCR Targeting Multiple Gene Segments: A Novel Approach to Screen for the Virus in Paraffin-Embedded Tissue and Plasma
Source:
Elsevier BV
Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas.
Source:
Informa UK Limited
Linking provided by
